NM_198173.3:c.165C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198173.3(GRHL3):​c.165C>G​(p.Asp55Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,613,514 control chromosomes in the GnomAD database, including 23,185 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2319 hom., cov: 32)
Exomes 𝑓: 0.17 ( 20866 hom. )

Consequence

GRHL3
NM_198173.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.461

Publications

21 publications found
Variant links:
Genes affected
GRHL3 (HGNC:25839): (grainyhead like transcription factor 3) This gene encodes a member of the grainyhead family of transcription factors. The encoded protein may function as a transcription factor during development, and has been shown to stimulate migration of endothelial cells. Multiple transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq, Aug 2010]
GRHL3 Gene-Disease associations (from GenCC):
  • van der Woude syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • van der Woude syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013997555).
BP6
Variant 1-24331573-C-G is Benign according to our data. Variant chr1-24331573-C-G is described in ClinVar as Benign. ClinVar VariationId is 1120074.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.202 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL3NM_198173.3 linkc.165C>G p.Asp55Glu missense_variant Exon 2 of 16 ENST00000361548.9 NP_937816.1 Q8TE85-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL3ENST00000361548.9 linkc.165C>G p.Asp55Glu missense_variant Exon 2 of 16 1 NM_198173.3 ENSP00000354943.5 Q8TE85-5

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25869
AN:
152002
Hom.:
2314
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.193
Gnomad SAS
AF:
0.148
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.165
Gnomad OTH
AF:
0.155
GnomAD2 exomes
AF:
0.158
AC:
39675
AN:
251202
AF XY:
0.155
show subpopulations
Gnomad AFR exome
AF:
0.206
Gnomad AMR exome
AF:
0.139
Gnomad ASJ exome
AF:
0.109
Gnomad EAS exome
AF:
0.191
Gnomad FIN exome
AF:
0.155
Gnomad NFE exome
AF:
0.161
Gnomad OTH exome
AF:
0.147
GnomAD4 exome
AF:
0.167
AC:
243937
AN:
1461394
Hom.:
20866
Cov.:
32
AF XY:
0.165
AC XY:
120267
AN XY:
727028
show subpopulations
African (AFR)
AF:
0.197
AC:
6595
AN:
33472
American (AMR)
AF:
0.137
AC:
6115
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
2899
AN:
26126
East Asian (EAS)
AF:
0.164
AC:
6506
AN:
39696
South Asian (SAS)
AF:
0.143
AC:
12332
AN:
86204
European-Finnish (FIN)
AF:
0.154
AC:
8236
AN:
53418
Middle Eastern (MID)
AF:
0.0624
AC:
360
AN:
5766
European-Non Finnish (NFE)
AF:
0.172
AC:
190809
AN:
1111628
Other (OTH)
AF:
0.167
AC:
10085
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
9561
19122
28682
38243
47804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6908
13816
20724
27632
34540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
25883
AN:
152120
Hom.:
2319
Cov.:
32
AF XY:
0.166
AC XY:
12371
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.206
AC:
8534
AN:
41478
American (AMR)
AF:
0.126
AC:
1931
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
370
AN:
3468
East Asian (EAS)
AF:
0.193
AC:
997
AN:
5162
South Asian (SAS)
AF:
0.148
AC:
714
AN:
4822
European-Finnish (FIN)
AF:
0.156
AC:
1654
AN:
10594
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.165
AC:
11208
AN:
67990
Other (OTH)
AF:
0.153
AC:
323
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1077
2153
3230
4306
5383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
1512
Bravo
AF:
0.171
TwinsUK
AF:
0.173
AC:
640
ALSPAC
AF:
0.170
AC:
656
ESP6500AA
AF:
0.207
AC:
911
ESP6500EA
AF:
0.164
AC:
1414
ExAC
AF:
0.159
AC:
19347
Asia WGS
AF:
0.169
AC:
588
AN:
3478
EpiCase
AF:
0.148
EpiControl
AF:
0.148

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31332962) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Feb 08, 2021
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Asp55Glu variant in GRHL3 is classified as benign because it has been identified in 15.97% (4526/282536) of total chromosomes in gnomAD, including 3777 homozygous individuals (http://gnomad.broadinstitute.org). ACMG/AMP criteria applied: BA1. -

Van der Woude syndrome 2 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
.;T;.;.;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.20
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.82
T;T;T;T;T
MetaRNN
Benign
0.0014
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;L;.;.;.
PhyloP100
0.46
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-2.3
N;N;N;D;N
REVEL
Benign
0.073
Sift
Benign
0.17
T;T;T;T;T
Sift4G
Benign
0.086
T;T;T;T;T
Polyphen
0.0030
.;.;.;.;B
Vest4
0.13
MutPred
0.44
Gain of disorder (P = 0.2314);Gain of disorder (P = 0.2314);.;.;.;
MPC
0.34
ClinPred
0.012
T
GERP RS
0.34
Varity_R
0.099
gMVP
0.36
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2486668; hg19: chr1-24658063; COSMIC: COSV52565223; API